The German biotech group BioNTech is sending two very different signals to the market at once. Its management is busy...

That warning comes from a series of recent rulings spanning wage claims, internal investigations, overtime disputes, and email delivery —...

The clock is ticking in two directions for XPeng. The electric-vehicle maker’s stock is hovering just a hair above its...

Elon Musk has tightened his stranglehold on the electric-vehicle maker, converting options from a 2018 compensation package into roughly 286...

The countdown has begun for Outlook Therapeutics, with the U.S. Food and Drug Administration setting a binding decision date of...

The gap between Deutsche Telekom's operational momentum and its stock price has rarely been wider. The shares closed near €26.94...

A diplomatic thaw between Washington and Tehran has sent crude prices into a tailspin, putting OMV’s market valuation squarely between...

Investors are piling into shares of Swedish chip developer Sivers Semiconductors at a pace that defies the turmoil unfolding in...

The €154 billion mountain of orders sitting on Siemens Energy’s books took centre stage in London this week, with finance...

The prevailing narrative around Micron Technology has shifted from cyclical commodity supplier to structural AI beneficiary — and Wall Street’s...